Coronavirus will ‘thrive in winter’ says doctor
The COVID-19 pandemic has caused considerable morbidity and mortality and has resulted in the death of over a million people to date. The clinical manifestations of the disease caused by the virus have been known to vary widely in severity, ranging from no or mild symptoms to rapid progression to respiratory failure. Now scientists have discovered the five genes which a person may have signalling the severity of a COVID-19 infection.
A major study from 2,700 COVID-19 patients from 208 ICU wards gathered DNA and were able to find the genes that makes a person more likely to die from the novel coronavirus or be admitted to intensive care.
The researchers found five genes which increase a person’s severity to the virus and hope by identifying them they can become targets for drugs.
The landmark study from the University of Edinburgh gathered DNA from 208 intensive care units across the UK for their analysis.
The genetic information of these 2,700 patients was then compared to 100,000 anonymous Britons with five genes emerging as being precursors for a serious COVID infection.
We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights.
After the genetic information was compared, five genes emerged as being extremely common in severe COVID-19 cases.
Researchers say the discovery of five genes that appear so clearly to be linked to the disease is unprecedented in the field.
Knowing which genes are involved in severe cases of coronavirus infection can help scientists identify pre-existing drugs that could help treat COVID-19, the researchers say.
How to live longer: Sex may reduce heart disease risk – how often you should have it [TIPS]
Dementia symptoms: Do you have toilet troubles? It could signal Lewy body dementia [INSIGHT]
Diabetes type 2 warning: What you need to know about drinking milk – blood sugar risks [ADVICE]
The five genes found were:
This gene encodes a member of the tyrosine kinase and, more specifically, the Janus kinases (JAKs) protein families.
The TYK2 gene creates an enzyme that can lead to inflammation.
This protein associates with the cytoplasmic domain of type I and type II cytokine receptors and promulgate cytokine signals by phosphorylating receptor subunits.
It is also a component of both the type I and type III interferon signalling pathways. As such, it may play a role in antiviral immunity.
Cytokines play pivotal roles in immunity and inflammation by regulating the survival, proliferation, differentiation, and function of immune cells, as well as cells from other organ systems.
Targetable by drugs that are in trials but are not widely used, for psoriasis.
Evidence for this gene is not as strong as for other genes in the study, but Dr Baillie says it is still ‘compelling’.
Is a gene that initiates a signal that activates an enzyme which degrades RNA derived from viruses.
Several other coronaviruses have a way of preventing this mechanism. No evidence yet for SARS-CoV-2, but it might be a specific feature that does this.
Targetable by a class of drugs called phosphodiesterase 12 inhibitors.
These are not currently in clinical trials but theoretically would enhance the antiviral effect of this system.
This is a core part of signalling that is responsible to the host antiviral response.
Signalling in this pathway is important in the chance of getting sick.
Relevant in fighting the virus directly, much like OAS1. This is more important early in the disease as later in the disease, virus levels drop, and the issue comes from the body’s immune system attacking itself.
Known to play several roles in inflammation but the researchers do not yet know exactly where it fits into the Covid-19 disease progression.
They are therefore unable to make a direct therapeutic prediction.
It is associated with pulmonary fibrosis and might be associated with ‘long covid’.
Source: Read Full Article